{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:10:45Z","timestamp":1769454645814,"version":"3.49.0"},"publisher-location":"Chichester, UK","reference-count":34,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004523.pub2","type":"reference-entry","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T23:08:27Z","timestamp":1137712107000},"source":"Crossref","is-referenced-by-count":4,"title":["Risedronate for the prevention and treatment of postmenopausal osteoporosis"],"prefix":"10.1002","author":[{"given":"A","family":"Cranney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JD","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"VA","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BJ","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Tugwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LM","family":"Waldegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Zytaruk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"10.1002\/14651858.CD004523.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/PL00004152","article-title":"A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis","volume":"7","author":"Clemmesen","year":"1997","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD004523.pub2-BIB2|cit2","first-page":"1895","article-title":"Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial","volume":"85","author":"Fogelman","year":"2000","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"14","key":"10.1002\/14651858.CD004523.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoprosis: A randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004523.pub2-BIB4|cit4","series-title":"26th European Symposium on Calcified Tissues","first-page":"S69","article-title":"Risedronate prevents bone loss in early postmenopausal women","author":"Hooper","year":"1999"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004523.pub2-BIB5|cit5","first-page":"111","article-title":"Risedronate increases bone mineral density at the hip, spine and radius in postmenopausal women with low bone mass","volume":"8","author":"McClung","year":"1998","journal-title":"Osteoporosis International"},{"issue":"5","key":"10.1002\/14651858.CD004523.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004523.pub2-BIB7|cit7","first-page":"396","article-title":"Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up","volume":"83","author":"Mortensen","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD004523.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with risedronate therapy (VERT) study group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD004523.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","article-title":"Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer","volume":"15","author":"Delmas","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004523.pub2-BIB10|cit10","series-title":"Calcified Tissue International","first-page":"0","article-title":"Risedronate reduces fracture risk in women with established postmenopausal osteoporosis","author":"Eastell","year":"1999"},{"key":"10.1002\/14651858.CD004523.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002512-199813010-00008","article-title":"Risedronate","volume":"13","author":"Goa","year":"1998","journal-title":"Drugs and Aging"},{"key":"10.1002\/14651858.CD004523.pub2-BIB12|cit12","first-page":"SA404","article-title":"The effects of risedronate plus estrogen compared with estrogen alone in postmenopausal women","author":"Harris","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"issue":"Supplement","key":"10.1002\/14651858.CD004523.pub2-BIB13|cit13","first-page":"1304","article-title":"Risedronate reduces the incidence of clincial fractures in postmenopausal women","volume":"42","author":"Kendler","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004523.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-199701000-00004","article-title":"Bisphosphonate therapy","volume":"313","author":"Licata","year":"1997","journal-title":"American Journal of Medical Sciences"},{"issue":"Supplement","key":"10.1002\/14651858.CD004523.pub2-BIB15|cit15","first-page":"287","article-title":"Risedronate reduces hip fractures in patients with low femoral neck bone mineral density","volume":"42","author":"Miller","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004523.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"34967","DOI":"10.1074\/jbc.274.49.34967","article-title":"Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst2 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase","volume":"274","author":"Rezda","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1002\/14651858.CD004523.pub2-BIB17|cit17","first-page":"S136","article-title":"Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density","volume":"14","author":"Ribot","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"issue":"Supplement","key":"10.1002\/14651858.CD004523.pub2-BIB18|cit18","first-page":"1300","article-title":"Risedronate rapidly reduces vertebral fracture risk in postmenopausal women with established osteoprosis","volume":"42","author":"Roux","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004523.pub2-BIB19|cit19","first-page":"259","article-title":"Bisphosphonates in the treatment of disorders of mineral metabolism","volume":"6","author":"Singer","year":"1995","journal-title":"Advances in Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004523.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0889-8529(05)70014-1","article-title":"Treatment of osteoporosis with bisphosphonates","volume":"27","author":"Watts","year":"1998","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1002\/14651858.CD004523.pub2-BIB21|cit21","first-page":"S136","article-title":"Risedronate reduces vertebral fracture risk after the first year of treatment in postmenopausal women with extablished osteoporosis","volume":"14","author":"Watts","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1002\/14651858.CD004523.pub2-BIB22|cit22","article-title":"2002 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada","volume":"5","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD004523.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a116756","article-title":"Population-based study of survival after osteoporosis fracture","volume":"137","author":"Cooper","year":"1993","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004523.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","article-title":"Meta-analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD004523.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"Statistical basis of analysis","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"10.1002\/14651858.CD004523.pub2-BIB26|cit26","first-page":"1","article-title":"Epidemiology of arthritis and osteoporosis","volume-title":"Patterns of Health Care in Ontario: Arthritis and Related Conditions: An ICES Practice Atlas","author":"Hawker","year":"1998"},{"key":"10.1002\/14651858.CD004523.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jamia.1994.95153434","article-title":"Developing optimal search strategies for detecting clinically sound studies in MEDLINE","volume":"1","author":"Haynes","year":"1994","journal-title":"J Am Med Info Ass"},{"issue":"1","key":"10.1002\/14651858.CD004523.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004523.pub2-BIB29|cit29","first-page":"105","article-title":"The impact and consequences of hip fracture in Ontario","volume":"39","author":"Jagal","year":"1996","journal-title":"Canadian Journal of Surgery"},{"key":"10.1002\/14651858.CD004523.pub2-BIB30|cit30","first-page":"143","article-title":"Osteoporosis fractures: Incidence and impact","volume-title":"Patterns of health care in Ontario: Arthritis and related conditions","author":"Jagal","year":"1998"},{"key":"10.1002\/14651858.CD004523.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1002\/14651858.CD004523.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD004523.pub2-BIB33|cit33","unstructured":"Osteoporosis; Clinical Guidelines for Prevention and Treatment London 2001"},{"key":"10.1002\/14651858.CD004523.pub2-BIB34|cit34","doi-asserted-by":"crossref","DOI":"10.1002\/9781444315844","volume-title":"Evidence-based Rheumatology","author":"Tugwell","year":"2003"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004523.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004523.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:36:25Z","timestamp":1628530585000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004523.pub2"}},"subtitle":[],"editor":[{"given":"Ann","family":"Cranney","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004523.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004523.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,1,25]]}}}